116
Participants
Start Date
November 2, 2018
Primary Completion Date
November 16, 2020
Study Completion Date
November 16, 2020
Tezepelumab
Tezepelumab subcutaneous injection
Placebo
Placebo subcutaneous injection
Research Site, København NV
Research Site, Hvidovre
Research Site, Næstved
Research Site, Odense C
Research Site, Vejle
Research Site, Aarhus N
Research Site, Aalborg
Research Site, Pittsburgh
Research Site, Großhansdorf
Research Site, Frankfurt am Main
Research Site, Frankfurt
Research Site, Galveston
Research Site, Denver
Research Site, Landsberg
Research Site, New Haven
Research Site, Boston
Research Site, Calgary
Research Site, Vancouver
Research Site, Hamilton
Research Site, Ottawa
Research Site, Montreal
Research Site, Québec
Research Site, Cambridge
Research Site, Headington
Research Site, Leicester
Research Site, London
Research Site, Nottingham
Research Site, Wythenshawe
Lead Sponsor
Collaborators (1)
Amgen
INDUSTRY
AstraZeneca
INDUSTRY